Spero Therapeutics, Inc. ($SPRO)
Filing Information
| Accession Number | 0001193125-26-038184 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 5, 2026 |
| Document Date | Feb 2, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
765,442
Total Value
$40,572.40
P&L
+inf% (+$1,837,620.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer, Chief Financial Officer and Chief Business Officer | Common Stock | โ | Feb 2, 2026 | Grant/Award | 249,000 | $0.00 | $0.00 | 1,118,450 | Direct | โ | View Details | |
Chief Executive Officer, Chief Financial Officer and Chief Business Officer | Common Stock | โ | Feb 2, 2026 | Sale | 18,442 | $2.20 | $40,572.40 | 1,100,008 | Direct | โ | View Details | |
Chief Executive Officer, Chief Financial Officer and Chief Business Officer | Stock Option (Right to Buy) | Derivative | Feb 2, 2026 | Grant/Award | 498,000 | $0.00 | $0.00 | 498,000 | Direct | โ | View Details |